The role of real-world data in advancement of Alzheimer’s treatments
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
Healthcare claims data are one of the most powerful sources of data in generating real-world...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million...
Closed claims no longer reflect real-world GLP-1 treatment patterns GLP-1 utilization continues to...
Know what others can’t with Symphony FLEX™: Market-agnostic healthcare data powering AI, investment research, pharma strategy, media and policy A pharmaceutical company may need to evaluate opportunities across its portfolio or explore a therapeutic ...